Evaluation of a Commercial Culture-free Neutralization Antibody Detection Kit for Severe Acute Respiratory Syndrome-Related Coronavirus-2 and Comparison with an Anti-RBD ELISA Assay
View ORCID ProfileJesse Papenburg, Matthew P. Cheng, Rachel Corsini, Chelsea Caya, Emelissa Mendoza, Kathy Manguiat, Heidi Wood, Michael A. Drebot, Gerasimos Zaharatos, Reneée Bazin, Guillaume Beaudoin-Bussières, Jérémie Prévost, View ORCID ProfileAndrés Finzi, Momar Ndao Dvm, View ORCID ProfileCedric P Yansouni
doi: https://doi.org/10.1101/2021.01.23.21250325
Jesse Papenburg
aDivision of Pediatric Infectious Diseases, Department of Pediatrics, Montreal Children’s Hospital, Montreal, Quebec, Canada
bDivision of Microbiology, Department of Clinical Laboratory Medicine, Optilab Montreal - McGill University Health Centre, Montreal, Quebec, Canada
cMcGill Interdisciplinary Initiative in Infection and Immunity, Montreal, Quebec, Canada
dDepartment of Epidemiology, Biostatistics, and Occupational Health, School of Population and Global Health, McGill University, Montreal, Quebec, Canada
MD MScMatthew P. Cheng
bDivision of Microbiology, Department of Clinical Laboratory Medicine, Optilab Montreal - McGill University Health Centre, Montreal, Quebec, Canada
cMcGill Interdisciplinary Initiative in Infection and Immunity, Montreal, Quebec, Canada
eDivision of Infectious Diseases, Department of Medicine, McGill University Health Centre, Montreal, Quebec, Canada
MDCMRachel Corsini
cMcGill Interdisciplinary Initiative in Infection and Immunity, Montreal, Quebec, Canada
MScChelsea Caya
cMcGill Interdisciplinary Initiative in Infection and Immunity, Montreal, Quebec, Canada
MScPHEmelissa Mendoza
fZoonotic Diseases and Special Pathogens, National Microbiology Laboratory, Public Health Agency of Canada, Winnipeg, Manitoba, Canada
Kathy Manguiat
fZoonotic Diseases and Special Pathogens, National Microbiology Laboratory, Public Health Agency of Canada, Winnipeg, Manitoba, Canada
Heidi Wood
fZoonotic Diseases and Special Pathogens, National Microbiology Laboratory, Public Health Agency of Canada, Winnipeg, Manitoba, Canada
Michael A. Drebot
fZoonotic Diseases and Special Pathogens, National Microbiology Laboratory, Public Health Agency of Canada, Winnipeg, Manitoba, Canada
Gerasimos Zaharatos
bDivision of Microbiology, Department of Clinical Laboratory Medicine, Optilab Montreal - McGill University Health Centre, Montreal, Quebec, Canada
cMcGill Interdisciplinary Initiative in Infection and Immunity, Montreal, Quebec, Canada
Reneée Bazin
gAffaires Médicales et Innovation, Héma-Québec, Québec, Quebec, Canada
PhDGuillaume Beaudoin-Bussières
hDépartement de Microbiologie, Infectiologie et Immunologie, Université de Montréal, Montreal, Quebec, Canada
iCentre de Recherche du CHUM, Montreal, Quebec, Canada
BScJérémie Prévost
hDépartement de Microbiologie, Infectiologie et Immunologie, Université de Montréal, Montreal, Quebec, Canada
iCentre de Recherche du CHUM, Montreal, Quebec, Canada
BScAndrés Finzi
hDépartement de Microbiologie, Infectiologie et Immunologie, Université de Montréal, Montreal, Quebec, Canada
iCentre de Recherche du CHUM, Montreal, Quebec, Canada
PhDMomar Ndao Dvm
cMcGill Interdisciplinary Initiative in Infection and Immunity, Montreal, Quebec, Canada
jNational Reference Centre for Parasitology, Montreal, Quebec, Canada
kJ.D. MacLean Centre for Tropical Diseases, McGill University, Montreal, Quebec, Canada
PhDCedric P Yansouni
bDivision of Microbiology, Department of Clinical Laboratory Medicine, Optilab Montreal - McGill University Health Centre, Montreal, Quebec, Canada
cMcGill Interdisciplinary Initiative in Infection and Immunity, Montreal, Quebec, Canada
eDivision of Infectious Diseases, Department of Medicine, McGill University Health Centre, Montreal, Quebec, Canada
kJ.D. MacLean Centre for Tropical Diseases, McGill University, Montreal, Quebec, Canada
MD
Article usage
Posted January 26, 2021.
Evaluation of a Commercial Culture-free Neutralization Antibody Detection Kit for Severe Acute Respiratory Syndrome-Related Coronavirus-2 and Comparison with an Anti-RBD ELISA Assay
Jesse Papenburg, Matthew P. Cheng, Rachel Corsini, Chelsea Caya, Emelissa Mendoza, Kathy Manguiat, Heidi Wood, Michael A. Drebot, Gerasimos Zaharatos, Reneée Bazin, Guillaume Beaudoin-Bussières, Jérémie Prévost, Andrés Finzi, Momar Ndao Dvm, Cedric P Yansouni
medRxiv 2021.01.23.21250325; doi: https://doi.org/10.1101/2021.01.23.21250325
Evaluation of a Commercial Culture-free Neutralization Antibody Detection Kit for Severe Acute Respiratory Syndrome-Related Coronavirus-2 and Comparison with an Anti-RBD ELISA Assay
Jesse Papenburg, Matthew P. Cheng, Rachel Corsini, Chelsea Caya, Emelissa Mendoza, Kathy Manguiat, Heidi Wood, Michael A. Drebot, Gerasimos Zaharatos, Reneée Bazin, Guillaume Beaudoin-Bussières, Jérémie Prévost, Andrés Finzi, Momar Ndao Dvm, Cedric P Yansouni
medRxiv 2021.01.23.21250325; doi: https://doi.org/10.1101/2021.01.23.21250325
Subject Area
Subject Areas
- Addiction Medicine (349)
- Allergy and Immunology (668)
- Allergy and Immunology (668)
- Anesthesia (181)
- Cardiovascular Medicine (2648)
- Dermatology (223)
- Emergency Medicine (399)
- Epidemiology (12228)
- Forensic Medicine (10)
- Gastroenterology (759)
- Genetic and Genomic Medicine (4103)
- Geriatric Medicine (387)
- Health Economics (680)
- Health Informatics (2657)
- Health Policy (1005)
- Hematology (363)
- HIV/AIDS (851)
- Medical Education (399)
- Medical Ethics (109)
- Nephrology (436)
- Neurology (3882)
- Nursing (209)
- Nutrition (577)
- Oncology (2030)
- Ophthalmology (585)
- Orthopedics (240)
- Otolaryngology (306)
- Pain Medicine (250)
- Palliative Medicine (75)
- Pathology (473)
- Pediatrics (1115)
- Primary Care Research (452)
- Public and Global Health (6527)
- Radiology and Imaging (1403)
- Respiratory Medicine (871)
- Rheumatology (409)
- Sports Medicine (342)
- Surgery (448)
- Toxicology (53)
- Transplantation (185)
- Urology (165)